09/27/2026
Here is a capital question worth considering.
What happens when a significant global healthcare need, a recurring treatment model and an opportunity to expand access come together?
As a member of the Board of Directors of Niihara International, and an investor in the company, when I talk about Conscious Capitalism, this is precisely the kind of opportunity I mean.
Start with the need:
50+ million people affected by sickle cell disease worldwide.
Approximately 80% are in Sub-Saharan Africa.
Niihara International is focused on expanding international access to its sickle cell therapeutic, including in Africa and our immediate active focus, the Democratic Republic of the Congo. The First Lady Denise Nyakeru Tshisekedi has actively championed the fight against sickle cell disease, including advocacy for improved health services and making sickle cell disease a priority for support through her foundation.
Now look at the potential scale.
Take only 1% of a 50+ million affected population.
That is approximately:
500,000 patients
With a monthly recurring treatment:
500,000 × 12 = 6,000,000 treatment units annually
Then consider the modeled economics:
~70% Gross Margin
~40% Net Margin
Recurring Monthly Treatment
A Significant, Underserved International Market
I am not publishing the modeled treatment price here.
A serious investor does not need me to.
Choose a reasonable treatment value and do the math.
Then consider what increasing patient pe*******on could mean.
1%.
2%.
5%.
Not simply as a financial model but as people gaining access to treatment that can improve their lives.
That is the intersection I find compelling.
Mission. Access. Scale. Recurring economics. Impact.
Capital has the ability to help build companies while helping solve
meaningful problems.
That is Conscious Capitalism.
Niihara International is currently raising capital, and I am especially interested in conversations with individuals and organizations capable of considering meaningful capital participation. If that describes you, I invite you to contact me directly.
The cause is clear. The numbers are too.
Serious capital inquiries only.
